Artios Pharma Funding: $186M Raised, Series C (2021)

Artios Pharma is based in Cambridge, null. It has raised $186M in total funding. Latest round: Series C. Backed by Omega Funds, TCG X, Avidity Partners.

Artios Pharma funding overview

Artios Pharma is based in Cambridge, null. Artios Pharma has raised $186M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Artios Pharma runs through 2021; nothing later has been disclosed. Investors on record include Omega Funds, TCG X, Avidity Partners, Invus, Deep Track Capital, Sofinnova Partners and 14 others. 20 distinct backers are named across the disclosed rounds.

Artios Pharma at a glance

Total raised
$186M
Latest round
Series C
Latest round date
July 2021
Headquarters
Cambridge, null
Notable investors
Omega Funds, TCG X, Avidity Partners, Invus, Deep Track Capital, Sofinnova Partners, Tetragon Financial Group, RTW Investments LP

Frequently asked about Artios Pharma funding

How much has Artios Pharma raised?
Artios Pharma has raised $186M in total disclosed funding across the rounds on record.
Who has invested in Artios Pharma?
Omega Funds, TCG X, Avidity Partners, Invus, Deep Track Capital, Sofinnova Partners are named among the investors backing Artios Pharma.
What was the latest Artios Pharma funding round?
The most recent disclosed round is a Series C, announced in July 2021.
Where is Artios Pharma based?
Artios Pharma is based in Cambridge, null.
When did Artios Pharma last raise?
The last disclosed Artios Pharma round closed in July 2021 at Series C.

Every Artios Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to Artios Pharma (36)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026